3 ASX Penny Stocks With Market Caps Under A$600M To Consider

Feb 1, 2026
3-asx-penny-stocks-with-market-caps-under-a$600m-to-consider

Simply Wall St

4 min read

As the Australian market shows signs of recovery, with the ASX 200 futures indicating a potential uptick, investors are keeping a close eye on various opportunities. Penny stocks, often associated with smaller or newer companies, remain an intriguing area for those looking to diversify their portfolios beyond well-known names. Despite being considered somewhat outdated as a term, penny stocks continue to offer potential growth opportunities when backed by strong financial health.

Name

Share Price

Market Cap

Financial Health Rating

Dusk Group (ASX:DSK)

A$0.865

A$53.86M

★★★★★★

IVE Group (ASX:IGL)

A$3.01

A$463.96M

★★★★★☆

MotorCycle Holdings (ASX:MTO)

A$2.77

A$204.6M

★★★★★★

Veris (ASX:VRS)

A$0.07

A$37.83M

★★★★★★

West African Resources (ASX:WAF)

A$3.69

A$4.22B

★★★★★★

SKS Technologies Group (ASX:SKS)

A$3.53

A$407.08M

★★★★★★

Service Stream (ASX:SSM)

A$2.28

A$1.4B

★★★★★★

Australian Ethical Investment (ASX:AEF)

A$4.59

A$520.6M

★★★★★★

MaxiPARTS (ASX:MXI)

A$2.18

A$121.09M

★★★★★★

Hansen Technologies (ASX:HSN)

A$4.96

A$1.01B

★★★★★★

Click here to see the full list of 415 stocks from our ASX Penny Stocks screener.

Let’s take a closer look at a couple of our picks from the screened companies.

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Australian Clinical Labs Limited operates in Australia, offering pathology diagnostic services, with a market cap of A$521.15 million.

Operations: The company generates revenue of A$741.27 million from its pathology and clinical laboratory services segment.

Market Cap: A$521.15M

Australian Clinical Labs (ACL) presents a mixed picture for penny stock investors. With a market cap of A$521.15 million and revenue of A$741.27 million, the company is trading at 88.9% below its estimated fair value, suggesting potential upside. Its debt is well covered by operating cash flow, and interest payments are adequately managed with EBIT coverage of 4.8 times, indicating financial stability despite short-term liabilities exceeding assets. However, ACL’s board lacks experience with an average tenure of 1.7 years, which may affect strategic direction. Earnings growth has been strong recently but follows years of decline.

ASX:ACL Financial Position Analysis as at Feb 2026

ASX:ACL Financial Position Analysis as at Feb 2026

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: EDU Holdings Limited, with a market cap of A$112.99 million, operates through its subsidiaries to provide tertiary education services in Australia.


Leave a comment